Advertisement

Nucleotide Metabolism and Enzyme Inhibitors in Thymic Acute Lymphoblastic Leukaemia

  • A. V. Hoffbrand
  • D. D. F. Ma
  • H. G. Prentice
Conference paper
Part of the Haematology and Blood Transfusion / Hämatologie und Bluttransfusion book series (HAEMATOLOGY, volume 28)

Abstract

It is now clear that not only the immunological but also the biochemical characteristics of leukaemia cells are similar to those of the normal cells from which they arise. This has been most clearly established for the lymphoid malignancies and particularly in thymic-derived acute lymphoblastic leukaemia (Thy-ALL). Close similarities between Thy-ALL leukaemic blast cells and early cortical thymocytes in surface membrane antigen phenotype, in terminal deoxyribonucleotidyl transferase (TdT) content and in pattern of purine enzymes have recently been established [5]. These findings have helped to establish the exact cell of origin of Thy-ALL and made possible its diagnosis by single cell analysis in bone marrow or extra medullary sites. They have also led to the treatment of this disease with 2′ deoxycoformycin (dCF), a specific inhibitor of the purine degradative enzyme, adenosine deaminase (ADA). Part of the stimulus to this research into the biochemistry of the thymus and the treatment of Thy-ALL with dCF has arisen from observations on children with severe defects of immune development due to congenital deficiency of ADA or of a second purine degradative enzyme, purine nucleoside phosphorylase (PNP). Lack of these enzymes causes absence of T- and B-lymphocytes or of T-lymphocytes respectively but other functions of the body, including haemopoiesis are largely unaffected.

Keywords

Blast Cell Adenosine Deaminase Purine Nucleoside Phosphorylase Cortical Thymocyte Thymine Nucleotide 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Barton R, Martiniuk F, Hirschhorn R, Goldschneider I (1980) Inverse relationship between adenosine deaminase and purine nucleoside phosphorylase in rat lymphocyte populations. Cell Immunol 49:208–214PubMedCrossRefGoogle Scholar
  2. 2.
    Carson DA, Kaye J, Watson DB (1981) The potential importance of soluble deoxynucleotidase activity in mediating deoxyguanosine toxicity in human lymphoblasts. J Immunol 126:348–452PubMedGoogle Scholar
  3. 3.
    Fox RM, Kefford RF, Tripp EH, Taylor IW (1981) G1-phase arrest of cultured human leukemic T-cells induced by deoxyadenosine. Cancer Res 41:5141–5150PubMedGoogle Scholar
  4. 4.
    Grever MR, Siaw MFE, Jacob WF, Neidhart JA, Miser JS, Coleman MS, Hutton JJ, Balcerzak SP (1981) The biochemical and clinical consequences of 2′-deoxycoformycin in refractory lymphoproliferative malignancy. Blood 57:406–417PubMedGoogle Scholar
  5. 5.
    Hoffbrand AV, Janossy G (1981) Enzyme and membrane markers in leukaemia: Recent developments. J Clin Path 34:254–262PubMedCrossRefGoogle Scholar
  6. 6.
    Hoffbrand AV, Ma DDF, Webster ADB (1982) Enzyme patterns in normal lymphocyte subpopulations, lymphoid leukaemias and immunodeficiency syndromes. Clin Haematol 11:719–741PubMedGoogle Scholar
  7. 7.
    Janossy G, Bollum FJ, Bradstock KF, McMichael A, Rapson N, Greaves MF (1979) Terminal transferase-positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia. J Immunol 123: 1525–1529PubMedGoogle Scholar
  8. 8.
    Kefford RF, Fox RM (1982a) Purine deoxynucleoside toxicity in nondividing human lymphoid cells. Cancer Res 42:324–330Google Scholar
  9. 9.
    Kefford RF, Fox RM (1982b) Deoxycoformycin-induced response in chronic lymphocytic leukaemia: deoxyadenosine toxicity in non-replicating lymphocytes. Br J Haematol 50:627–636CrossRefGoogle Scholar
  10. 10.
    Kefford RF, Fox RM, McCairns E, Fahey D, Muscat GEO, Rowe PB (1982) Incorporation of 2′-deoxyadenosine into poly (A) RNA of human T lymphoblasts. (Abst.) J Clin Chem Clin Biochem 20: 383Google Scholar
  11. 11.
    Lee N, Ganeshaguru K, Gray DA, Jackson BFA, Piga A, Prentice HG, Hoffbrand AV (to be published) Mechanisms of deoxyadenosine toxicity in human lymphoid cells in vitroGoogle Scholar
  12. 12.
    Ma DDF, Sylwestrowicz TA, Granger S, Massaia M, Franks R, Janossy G, Hoffbrand AV (1982) Distribution of terminal deoxynucleotide transferase, purine degradative and synthetic enzymes in subpopulations of human thymocytes. J Immunol 129: 1430–1435PubMedGoogle Scholar
  13. 13.
    Ma DDF, Sylwestrowicz TA, Janossy G, Hoffbrand AV (to be published) The role of purine metabolic enzymes and terminal deoxynucleotidyl transferase in intrathymic T cell differentiation. Immunology TodayGoogle Scholar
  14. 14.
    Ma DDF, Massaia M, Sylwestrowicz TA, Price G, Hoffbrand AV (1983) Comparison of purine degradative enzymes and TdT in T-cell leukaemias and in normal thymic and post thymic T cells. Br J Haematol (in press)Google Scholar
  15. 15.
    Massaia M, Ma DDF, Sylwestrowicz TA, Tidman N, Price G, Janossy G, Hoffbrand AV (1982) Enzymes of purine metabolism in human peripheral lymphocyte populations. Clin Exp Immunol 50: 148–154PubMedGoogle Scholar
  16. 16.
    Piga A, Ganeshaguru K, Lee N, Breatnach F, Prentice HG, Hoffbrand AV (1981) DNA synthesis in thymic-acute lymphoblastic leukaemia. Br J Haematol 48:585–594PubMedCrossRefGoogle Scholar
  17. 17.
    Piga A, Ganeshaguru K, Sylwestrowicz T, Breatnach F, Prentice HG, Hoffbrand AV (1982) Nucleoside incorporation into DNA and RNA in acute leukaemia. Differences between the various leukaemia sub-types. Br J Haematol 52: 195–204PubMedCrossRefGoogle Scholar
  18. 18.
    Prentice HG, Russell NH, Lee N, Ganeshaguru K, Blacklock H, Piga A, Smith JF, Hoffbrand AV (1981) Therapeutic selectivity and prediction of response to 2′deoxycoformycin in acute leukaemia. Lancet II: 1250–1254CrossRefGoogle Scholar
  19. 19.
    Russell N, Prentice HG, Lee N, Piga A, Ganeshaguru K, Smyth JF, Janossy G, Hoffbrand AV (1980) Studies on the biochemical sequelae of therapy in Thy-acute leukaemia with the adenosine deaminase inhibitor 2′deoxycoformycin. Br J Haematol 49: 1–9CrossRefGoogle Scholar
  20. 20.
    Sylwestrowicz TA, Ma DDF, Murphy PP, Prentice HG, Hoffbrand AV, Greaves MF (1982) 5′nucleotidase, adenosine deaminase and purine nucleoside phosphorylase activities in acute leukaemia. Leuk Res 4:475–482CrossRefGoogle Scholar
  21. 21.
    Sylwestrowicz T, Piga A, Murphy P, Ganeshaguru K, Russell NH, Prentice HG, Hoffbrand AV (1982) The effects of deoxycoformycin and deoxyadenosine on deoxyribonucleotide concentrations in leukaemic cells. Br J Haematol 51: 623–630PubMedCrossRefGoogle Scholar
  22. 22.
    Taheri MR, Wickremasinghe RG, Hoffbrand AV (1981) Alternative metabolic fates of thymine nucleotides in human cells. Biochem J 196:225–235PubMedGoogle Scholar
  23. 23.
    Taheri MR, Wickremasinghe RG, Hoffbrand AV (1982) Functional compartmentalisation of DNA precursors in human leukaemoblastoid cell lines. Br J Haematol 52: 401–410PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1983

Authors and Affiliations

  • A. V. Hoffbrand
  • D. D. F. Ma
  • H. G. Prentice

There are no affiliations available

Personalised recommendations